Sponsor

Jonsson Comprehensive Cancer Center

Clinical research sponsor

Published trials163
Recruiting shown25
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI TrialNCT07191717 · lead sponsor · 2026-05-18
RECRUITING
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate CancerNCT07468903 · lead sponsor · 2026-05-11
RECRUITING
Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung CancerNCT07323641 · lead sponsor · 2026-02-19
RECRUITING
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray TreatmentNCT07293585 · lead sponsor · 2025-12-16
RECRUITING
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung AdenocarcinomaNCT07235280 · lead sponsor · 2025-12-02
RECRUITING
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE TrialNCT07276438 · lead sponsor · 2025-12-01
RECRUITING
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON TrialNCT07164027 · lead sponsor · 2025-11-14
RECRUITING
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult PatientsNCT06934239 · lead sponsor · 2025-10-15
RECRUITING
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.NCT07185165 · lead sponsor · 2025-10-09
RECRUITING
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing ToxicityNCT07077239 · lead sponsor · 2025-07-17
RECRUITING
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA TrialNCT06288113 · lead sponsor · 2024-08-01
RECRUITING
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)NCT06216249 · lead sponsor · 2024-08-01
RECRUITING
Prevention of Frailty With Fisetin and Exercise in Breast Cancer SurvivorsNCT06113016 · lead sponsor · 2024-07-23
RECRUITING
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand TherapyNCT05398302 · lead sponsor · 2024-04-26
RECRUITING
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE TrialNCT06067269 · lead sponsor · 2024-03-28
RECRUITING
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible ParticipantsNCT05978128 · lead sponsor · 2023-07-28
RECRUITING
Fisetin to Improve Physical Function in Stage I-III Breast Cancer SurvivorsNCT05595499 · lead sponsor · 2023-03-27
RECRUITING
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung CancerNCT05558904 · lead sponsor · 2023-01-19
RECRUITING
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaNCT04945642 · lead sponsor · 2021-08-20
RECRUITING
99mTc-PSMA-I&S Biodistribution in Patients With Prostate CancerNCT04857502 · lead sponsor · 2021-04-27
RECRUITING
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer ClassificationNCT04765150 · lead sponsor · 2021-04-01
RECRUITING
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerNCT04553770 · lead sponsor · 2020-10-09
RECRUITING
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell TransplantNCT04453072 · lead sponsor · 2020-07-01
RECRUITING
Brain Health in Breast Cancer SurvivorsNCT04297020 · lead sponsor · 2020-03-11
RECRUITING
Active Surveillance for Cancer of the Prostate (ASCaP)NCT00949819 · lead sponsor · 2009-07-04
RECRUITING
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung CancerNCT07229339 · lead sponsor · 2027-06-01
NOT_YET_RECRUITING
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersNCT07118176 · lead sponsor · 2025-08-01
ACTIVE_NOT_RECRUITING
Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION TrialNCT06995053 · lead sponsor · 2025-06-27
ACTIVE_NOT_RECRUITING
Registry of Patients Undergoing Cryoablation for Early Stage Breast CancerNCT06387173 · lead sponsor · 2024-01-04
ACTIVE_NOT_RECRUITING
Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for GuidanceNCT06047509 · lead sponsor · 2023-09-14
TERMINATED
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR StudyNCT05496959 · lead sponsor · 2022-09-02
ACTIVE_NOT_RECRUITING
Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast CancerNCT05319873 · lead sponsor · 2022-04-07
ACTIVE_NOT_RECRUITING
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive BiopsyNCT05160597 · lead sponsor · 2022-01-13
ACTIVE_NOT_RECRUITING
Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer SurvivorsNCT04290897 · lead sponsor · 2021-09-29
COMPLETED
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical ProstatectomyNCT04915508 · lead sponsor · 2021-06-23
ACTIVE_NOT_RECRUITING
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyNCT04928820 · lead sponsor · 2021-06-16
TERMINATED
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNCT04705025 · lead sponsor · 2021-04-08
TERMINATED
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerNCT03902951 · lead sponsor · 2021-03-17
ACTIVE_NOT_RECRUITING
Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung CancerNCT04285671 · lead sponsor · 2021-01-29
ACTIVE_NOT_RECRUITING
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA TrialNCT04624256 · lead sponsor · 2020-11-10
ACTIVE_NOT_RECRUITING
Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical ProstatectomyNCT04299620 · lead sponsor · 2020-10-21
ACTIVE_NOT_RECRUITING
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology ValidationNCT04457232 · lead sponsor · 2020-09-09
ACTIVE_NOT_RECRUITING
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate CancerNCT04457245 · lead sponsor · 2020-08-14
TERMINATED
CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE StudyNCT04384770 · lead sponsor · 2020-05-12
ACTIVE_NOT_RECRUITING
Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerNCT04279561 · lead sponsor · 2020-04-16
TERMINATED
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate CancerNCT04399824 · lead sponsor · 2020-04-03
WITHDRAWN
Focal Laser Ablation of Prostate CancerNCT04305925 · lead sponsor · 2020-01-30
COMPLETED
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesNCT04147494 · lead sponsor · 2019-11-05
ACTIVE_NOT_RECRUITING
Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase InhibitorsNCT03953157 · lead sponsor · 2019-10-07
COMPLETED
Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deletedNCT04185311 · lead sponsor · 2019-07-10
TERMINATED
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung CancerNCT03546361 · lead sponsor · 2019-07-08
ACTIVE_NOT_RECRUITING
Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate CancerNCT04282824 · lead sponsor · 2019-06-05
COMPLETED
Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After SurgeryNCT03515577 · lead sponsor · 2019-04-12
COMPLETED
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast CancerNCT03411070 · lead sponsor · 2019-04-07
COMPLETED
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyNCT03830918 · lead sponsor · 2019-03-06
ACTIVE_NOT_RECRUITING
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone SurgeryNCT03541850 · lead sponsor · 2019-01-29
ACTIVE_NOT_RECRUITING
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or ProstateNCT03582475 · lead sponsor · 2019-01-11
ACTIVE_NOT_RECRUITING
Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung CancerNCT03672773 · lead sponsor · 2018-10-31
ACTIVE_NOT_RECRUITING
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical ProstatectomyNCT03582774 · lead sponsor · 2018-07-12
ACTIVE_NOT_RECRUITING
Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand TherapyNCT03596710 · lead sponsor · 2018-06-14
WITHDRAWN

Sponsor roles

lead sponsor158
collaborator5

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.